200 related articles for article (PubMed ID: 18654864)
1. Formulation and evaluation of PLA and PLGA in situ implants containing secnidazole and/or doxycycline for treatment of periodontitis.
Gad HA; El-Nabarawi MA; Abd El-Hady SS
AAPS PharmSciTech; 2008; 9(3):878-84. PubMed ID: 18654864
[TBL] [Abstract][Full Text] [Related]
2. In-situ forming composite implants for periodontitis treatment: How the formulation determines system performance.
Do MP; Neut C; Metz H; Delcourt E; Mäder K; Siepmann J; Siepmann F
Int J Pharm; 2015; 486(1-2):38-51. PubMed ID: 25791762
[TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of secnidazole or doxycycline dento-oral gels.
Gad HA; el-Nabarawi MA; Abd el-Hady SS
Drug Dev Ind Pharm; 2008 Dec; 34(12):1356-67. PubMed ID: 18785044
[TBL] [Abstract][Full Text] [Related]
4. Minocycline-loaded In situ Hydrogel for Periodontitis Treatment.
Wang X; Ma J; Zhu X; Wang F; Zhou L
Curr Drug Deliv; 2018; 15(5):664-671. PubMed ID: 29165071
[TBL] [Abstract][Full Text] [Related]
5. Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.
Desai KG; Mallery SR; Schwendeman SP
Eur J Pharm Biopharm; 2008 Sep; 70(1):187-98. PubMed ID: 18472254
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.
Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM
J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres.
Kostanski JW; Thanoo BC; DeLuca PP
Pharm Dev Technol; 2000; 5(4):585-96. PubMed ID: 11109259
[TBL] [Abstract][Full Text] [Related]
8. In situ forming implants for the delivery of metronidazole to periodontal pockets: formulation and drug release studies.
Kilicarslan M; Koerber M; Bodmeier R
Drug Dev Ind Pharm; 2014 May; 40(5):619-24. PubMed ID: 24369747
[TBL] [Abstract][Full Text] [Related]
9. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
Desai KG; Mallery SR; Schwendeman SP
Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
[TBL] [Abstract][Full Text] [Related]
10. Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.
Kranz H; Ubrich N; Maincent P; Bodmeier R
J Pharm Sci; 2000 Dec; 89(12):1558-66. PubMed ID: 11042603
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of hCG-loaded polylactide or poly(lactide-co-glycolide) microspheres using a modified water-in-oil-in-water (w/o/w) emulsion solvent evaporation technique.
Zhu KJ; Jiang HL; Du XY; Wang J; Xu WX; Liu SF
J Microencapsul; 2001; 18(2):247-60. PubMed ID: 11253941
[TBL] [Abstract][Full Text] [Related]
12. Concomitant monitoring of implant formation and drug release of in situ forming poly (lactide-co-glycolide acid) implants in a hydrogel matrix mimicking the subcutis using UV-vis imaging.
Sun Y; Jensen H; Petersen NJ; Larsen SW; Østergaard J
J Pharm Biomed Anal; 2018 Feb; 150():95-106. PubMed ID: 29216591
[TBL] [Abstract][Full Text] [Related]
13. Rheological properties of PLGA film-based implants: correlation with polymer degradation and SPf66 antimalaric synthetic peptide release.
Santoveña A; Alvarez-Lorenzo C; Concheiro A; Llabrés M; Fariña JB
Biomaterials; 2004 Feb; 25(5):925-31. PubMed ID: 14609681
[TBL] [Abstract][Full Text] [Related]
14. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.
Prior S; Gamazo C; Irache JM; Merkle HP; Gander B
Int J Pharm; 2000 Feb; 196(1):115-25. PubMed ID: 10675713
[TBL] [Abstract][Full Text] [Related]
15. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants.
Ramchandani M; Robinson D
J Control Release; 1998 Jul; 54(2):167-75. PubMed ID: 9724903
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization and in vivo pharmacodynamic evaluation of thymopentin loaded poly(lactide acid)/poly(lactide-co-glycolide acid) implants.
Wei G; Jin L; Xu L; Liu Y; Lu W
Int J Pharm; 2010 Oct; 398(1-2):123-9. PubMed ID: 20674730
[TBL] [Abstract][Full Text] [Related]
18. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems.
Luan X; Bodmeier R
J Control Release; 2006 Jan; 110(2):266-272. PubMed ID: 16300851
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-induced degradation of PLA and PLGA during microsphere processing: influence of formulation variables.
Reich G
Eur J Pharm Biopharm; 1998 Mar; 45(2):165-71. PubMed ID: 9704913
[TBL] [Abstract][Full Text] [Related]
20. Release of metronidazole from electrospun poly(L-lactide-co-D/L-lactide) fibers for local periodontitis treatment.
Reise M; Wyrwa R; Müller U; Zylinski M; Völpel A; Schnabelrauch M; Berg A; Jandt KD; Watts DC; Sigusch BW
Dent Mater; 2012 Feb; 28(2):179-88. PubMed ID: 22226009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]